HMGB1 and hepatocellular carcinoma: Given that TLR4 and PTK2 are downstream effectors of the HMGB1-KLF7 axis, we explored whether the pharmacological inhibition of TLR4 and PTK2 could impede KLF7-mediated HCC development and metastasis.